Journal article
CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer.
- Abstract:
-
Human papilloma virus (HPV)-induced cervical cancer constitutively expresses viral E6/E7 oncoproteins and is an excellent target for T cell-based immunotherapy. However, not all tumor-infiltrating T cells confer equal benefit to patients, with epithelial T cells being superior to stromal T cells. To assess whether the epithelial T cell biomarker CD103 could specifically discriminate the beneficial antitumor T cells, association of CD103 with clinicopathological variables and outcome was analy...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1080/2162402x.2017.1338230
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Funding
Dutch Cancer Society
More from this funder
Jan Kornelis de Cock Stichting
More from this funder
Academy of Medical Sciences
More from this funder
Netherlands Organisation for Scientific Research
More from this funder
Oxford Cancer Center
More from this funder
Bibliographic Details
- Publisher:
- Taylor and Francis Publisher's website
- Journal:
- Oncoimmunology Journal website
- Volume:
- 6
- Issue:
- 9
- Pages:
- e1338230
- Publication date:
- 2017-07-01
- Acceptance date:
- 2017-05-30
- DOI:
- EISSN:
-
2162-402X
- ISSN:
-
2162-4011
- Pmid:
-
28932636
- Source identifiers:
-
730849
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:730849
- UUID:
-
uuid:3f2c5b6f-329b-49fb-a911-eef10dfcab0a
- Local pid:
- pubs:730849
- Deposit date:
- 2017-10-13
Terms of use
- Copyright holder:
- Church et al
- Copyright date:
- 2017
- Notes:
-
© 2017 Fenne L. Komdeur, Thalina M. Prins, Stephanie van de Wall, Annechien Plat, G. Bea A. Wisman, Harry Hollema, Toos Daemen, David N. Church, Marco de Bruyn and Hans W. Nijman. Published with license by Taylor and Francis. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
If you are the owner of this record, you can report an update to it here: Report update to this record